These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 22309603
1. How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? Ragonese M, Cotta OR, Ferraù F, Trimarchi F, Cannavò S. Gynecol Endocrinol; 2012 Aug; 28(8):637-9. PubMed ID: 22309603 [Abstract] [Full Text] [Related]
2. Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study. Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G. Clin Endocrinol (Oxf); 2011 Nov; 75(5):666-72. PubMed ID: 21554373 [Abstract] [Full Text] [Related]
4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M, Colao A, Toja PM, Lombardi G, Cavagnini F. Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996 [Abstract] [Full Text] [Related]
7. CRH in Cushing's syndrome. Müller OA, Stalla GK, von Werder K. Horm Metab Res Suppl; 1987 Feb; 16():51-8. PubMed ID: 2832289 [Abstract] [Full Text] [Related]
8. Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. Tirabassi G, Faloia E, Papa R, Furlani G, Boscaro M, Arnaldi G. J Clin Endocrinol Metab; 2010 Mar; 95(3):1115-22. PubMed ID: 20080839 [Abstract] [Full Text] [Related]
9. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome. Gatta B, Chabre O, Cortet C, Martinie M, Corcuff JB, Roger P, Tabarin A. J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947 [Abstract] [Full Text] [Related]
10. Course of pregnancies in women with Cushing's disease treated by gamma-knife. Ferraù F, Losa M, Cotta OR, Torre ML, Ragonese M, Trimarchi F, Cannavò S. Gynecol Endocrinol; 2012 Oct; 28(10):827-9. PubMed ID: 22571755 [Abstract] [Full Text] [Related]
11. Biochemical predictors of outcome of pituitary surgery for Cushing's disease. Alwani RA, de Herder WW, van Aken MO, van den Berge JH, Delwel EJ, Dallenga AH, De Jong FH, Lamberts SW, van der Lely AJ, Feelders RA. Neuroendocrinology; 2010 Oct; 91(2):169-78. PubMed ID: 19907141 [Abstract] [Full Text] [Related]
12. Evaluation of the DDAVP test in the diagnosis of Cushing's Disease. Rollin GA, Costenaro F, Gerchman F, Rodrigues TC, Czepielewski MA. Clin Endocrinol (Oxf); 2015 Jun; 82(6):793-800. PubMed ID: 25376361 [Abstract] [Full Text] [Related]
13. The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. Moro M, Putignano P, Losa M, Invitti C, Maraschini C, Cavagnini F. J Clin Endocrinol Metab; 2000 Oct; 85(10):3569-74. PubMed ID: 11061503 [Abstract] [Full Text] [Related]
14. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome. Barbot M, Trementino L, Zilio M, Ceccato F, Albiger N, Daniele A, Frigo AC, Mardari R, Rolma G, Boscaro M, Arnaldi G, Scaroni C. Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452 [Abstract] [Full Text] [Related]
15. [The desmopressin test in the diagnosis of Cushing's disease]. Gasińiska T, Dec R, Wichary H, Pietrasik L, Kulawik G. Pol Arch Med Wewn; 2007 Oct; 117(1-2):20-6. PubMed ID: 17642202 [Abstract] [Full Text] [Related]
16. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome. Vilar L, Freitas MC, Naves LA, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Arruda MJ, Silva LM, Arahata CM, Agra R, Lima LH, Azevedo M, Casulari LA. J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058 [Abstract] [Full Text] [Related]
17. Plasma corticotrophin response to desmopressin in patients with Cushing's disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours. Wang FF, Tang KT, Yen YS, Ho DM, Yang AH, Huang CI, Lin HD, Won JG. Clin Endocrinol (Oxf); 2012 Feb; 76(2):253-63. PubMed ID: 21781143 [Abstract] [Full Text] [Related]
18. Cushing's disease. Bertagna X, Guignat L, Groussin L, Bertherat J. Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):607-23. PubMed ID: 19945026 [Abstract] [Full Text] [Related]
19. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP. Adv Biochem Psychopharmacol; 1987 Oct; 43():183-200. PubMed ID: 3035886 [Abstract] [Full Text] [Related]
20. Predicting late recurrence in surgically treated patients with Cushing's disease. Barbot M, Albiger N, Koutroumpi S, Ceccato F, Frigo AC, Manara R, Fassina A, Gardiman MP, Scanarini M, Mantero F, Scaroni C. Clin Endocrinol (Oxf); 2013 Sep; 79(3):394-401. PubMed ID: 23278711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]